DNTH vs PHM · rev $6.2M vs P/E 7.7, rev $17.95B
Dianthus Therapeutics Inc. (DNTH) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
DNTH currently screens at market cap $4.40B. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the DNTH and PHM stock pages for the full models.
Not investment advice.